BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23267126)

  • 1. Genistein and daidzein: different molecular effects on prostate cancer.
    Adjakly M; Ngollo M; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
    Anticancer Res; 2013 Jan; 33(1):39-44. PubMed ID: 23267126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells.
    Hsu A; Bray TM; Helferich WG; Doerge DR; Ho E
    Exp Biol Med (Maywood); 2010 Jan; 235(1):90-7. PubMed ID: 20404023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines.
    Adjakly M; Bosviel R; Rabiau N; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
    Epigenomics; 2011 Dec; 3(6):795-803. PubMed ID: 22126297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide DNA methylation modified by soy phytoestrogens: role for epigenetic therapeutics in prostate cancer?
    Karsli-Ceppioglu S; Ngollo M; Adjakly M; Dagdemir A; Judes G; Lebert A; Boiteux JP; Penault-LLorca F; Bignon YJ; Guy L; Bernard-Gallon D
    OMICS; 2015 Apr; 19(4):209-19. PubMed ID: 25831061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone.
    Dong X; Xu W; Sikes RA; Wu C
    Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes.
    Davis JN; Kucuk O; Djuric Z; Sarkar FH
    Free Radic Biol Med; 2001 Jun; 30(11):1293-302. PubMed ID: 11368927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soy isoflavones and cancer prevention.
    Sarkar FH; Li Y
    Cancer Invest; 2003; 21(5):744-57. PubMed ID: 14628433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daidzein effect on hormone refractory prostate cancer in vitro and in vivo compared to genistein and soy extract: potentiation of radiotherapy.
    Singh-Gupta V; Zhang H; Yunker CK; Ahmad Z; Zwier D; Sarkar FH; Hillman GG
    Pharm Res; 2010 Jun; 27(6):1115-27. PubMed ID: 20309614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soy, isoflavones, and prostate cancer.
    Jian L
    Mol Nutr Food Res; 2009 Feb; 53(2):217-26. PubMed ID: 18985655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soy isoflavones in the treatment of prostate cancer.
    Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O
    Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of soy phytoestrogens and 17β-estradiol on DNA methylation of a panel of 24 genes in prostate cancer cell lines.
    Adjakly M; Ngollo M; Lebert A; Dagdemir A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
    Nutr Cancer; 2014; 66(3):474-82. PubMed ID: 24641702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of soy phytoestrogens in prostate cancer.
    Castle EP; Thrasher JB
    Urol Clin North Am; 2002 Feb; 29(1):71-81, viii-ix. PubMed ID: 12109358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effects of soy phytoestrogens on rat L6 skeletal muscle cells.
    Jones KL; Harty J; Roeder MJ; Winters TA; Banz WJ
    J Med Food; 2005; 8(3):327-31. PubMed ID: 16176142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soy product and isoflavone consumption in relation to prostate cancer in Japanese men.
    Kurahashi N; Iwasaki M; Sasazuki S; Otani T; Inoue M; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):538-45. PubMed ID: 17337648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of cancer chemoprevention by soy isoflavone genistein.
    Sarkar FH; Li Y
    Cancer Metastasis Rev; 2002; 21(3-4):265-80. PubMed ID: 12549765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of a major soy isoflavone, genistein, on human DNA topoisomerase II activity and cancer cell proliferation.
    Mizushina Y; Shiomi K; Kuriyama I; Takahashi Y; Yoshida H
    Int J Oncol; 2013 Oct; 43(4):1117-24. PubMed ID: 23900272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular signatures of soy-derived phytochemicals in androgen-responsive prostate cancer cells: a comparison study using DNA microarray.
    Takahashi Y; Lavigne JA; Hursting SD; Chandramouli GV; Perkins SN; Kim YS; Wang TT
    Mol Carcinog; 2006 Dec; 45(12):943-56. PubMed ID: 16865672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer.
    Magee PJ; Rowland IR
    Br J Nutr; 2004 Apr; 91(4):513-31. PubMed ID: 15035679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
    Raffoul JJ; Banerjee S; Che M; Knoll ZE; Doerge DR; Abrams J; Kucuk O; Sarkar FH; Hillman GG
    Int J Cancer; 2007 Jun; 120(11):2491-8. PubMed ID: 17304503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genistein and daidzein act on a panel of genes implicated in cell cycle and angiogenesis by polymerase chain reaction arrays in human prostate cancer cell lines.
    Rabiau N; Kossaï M; Braud M; Chalabi N; Satih S; Bignon YJ; Bernard-Gallon DJ
    Cancer Epidemiol; 2010 Apr; 34(2):200-6. PubMed ID: 20097631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.